Reducing sodium intake to lower heart disease risk in the U.S.
Population strategies to reduce sodium intake and cardiovascular diseases in the United States: Applying RE-AIM to policy implementation
['FUNDING_CAREER'] · UNIVERSITY OF WASHINGTON · NIH-11001235
This study is looking at ways to help everyone eat less salt, which can lead to better heart health, by testing different ideas like changing food recipes and teaching people about healthy eating.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11001235 on ClinicalTrials.gov |
What this research studies
This research focuses on strategies to lower sodium consumption across the U.S. population, which is linked to high rates of cardiovascular disease (CVD). By applying the RE-AIM framework, the project aims to evaluate the effectiveness of various sodium reduction policies, such as product reformulation and public education campaigns. The goal is to provide policymakers with actionable insights to implement these strategies effectively, ultimately improving cardiovascular health outcomes. Patients may benefit from reduced sodium intake through healthier food options and increased awareness of dietary choices.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for cardiovascular diseases, particularly those with high sodium intake or related health conditions.
Not a fit: Patients who already have low sodium intake or those with conditions unrelated to sodium consumption may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in cardiovascular disease rates by promoting lower sodium consumption.
How similar studies have performed: Previous research has shown that population-level interventions can effectively reduce sodium intake and improve cardiovascular health, indicating a promising approach.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SU, YANFANG — UNIVERSITY OF WASHINGTON
- Study coordinator: SU, YANFANG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.